Array Tomography Hardware and Software Development
Array Tomography Hardware and Software Development
批准号:
8123932
负责人:
JAY K TRAUTMAN
金额:
$33.43万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-22 至 2012-09-21
关键词:
AddressAgeAlzheimer&aposs DiseaseAreaBasic ScienceBiological Neural NetworksBrainCodeColorCommunitiesComputer softwareDataData SetDatabasesDetectionDevelopmentDiagnosticDimensionsDiseaseEpitopesFailureFluorescenceGoalsHuntington DiseaseImageIndividualLaboratoriesLightingMedicalMetadataMethodsMicroscopeMicroscopicMolecularMonitorNerve DegenerationNeurodegenerative DisordersNeurosciencesOpticsParkinson DiseasePhasePopulationPreparationProceduresProcessProductionProtocols documentationPublicationsPublishingResearchResearch PersonnelResolutionRetrievalRunningSamplingServicesSliceSpecimenStructureSynapsesSystemTechniquesTechnologyTherapeuticTimeTissuesUrsidae Familyanticancer researchbasecellular pathologycommercializationcostdatabase structuredesigneffective therapyflexibilityhuman diseaseimage processingindexinginstrumentmeetingsmillimeterneural circuitnovelopen sourceoperationprogramsprototypereconstructionsoftware developmenttherapeutic developmenttomography
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Understanding the structure and function of the brain is one of the great scientific problems. Neurodegenerative conditions of the brain are among the most expensive, disruptive, and least well-treated human diseases, arguably because they are not well understood, which precludes a rational approach to treatment. Array Tomography is a new method for tissue imaging with resolution in all three dimensions sufficient to resolve individual synapses and with quantitative characterization of multiple (currently 36) molecular constituents, throughout a 1-mm3 sample. What this means is that it is now possible to construct the wiring diagram of a neural circuit, consisting of a few 100 million to a billion synapses with precise description of the molecular constituents. We believe that this kind of information will enable researchers to begin to comprehend the proper function of neural circuits and, importantly, to begin to understand how it is that the various neurodegenerative processes present and progress. As alluring as this prospect is, Array Tomography has been used in relatively few studies following the inaugural publication in 2007 (Micheva and Smith, 2007), due to the complexity of the method and the cost of establishing it in the lab of an individual investigator. The commercial opportunity is to offer Array Tomography as a service to the research community. We believe this is the best way to bring the power of the method to bear on problems in neuroscience, cancer research, and medical diagnostic and therapeutic development. To that end, in this proposal we seek to refine the procedures developed in the Smith laboratory so that it will be possible to offer array tomography as a service to the academic and industrial communities. Specifically, we propose to develop a single-purpose imaging instrument, including control software that will allow a many-fold increase in tissue slice imaging. In addition, we propose to develop an image storage and retrieval system to enhance the commercial use of array tomography.
PUBLIC HEALTH RELEVANCE: Neurodegenerative diseases, such as Alzheimer's and Parkinson's are becoming more and more prevalent as the population ages. Efforts to develop treatments for these diseases have been hampered by a lack of technologies that provide "big picture" information about how these diseases progress. We propose to develop a technology for high-resolution microscopic analysis of large brain areas to more fully understand the cellular pathologies caused by these diseases so that more effective treatments can be discovered.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Labeling method for high-resolution imaging of hundreds of tissue antigens
-
批准号:8904759
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2015
-
负责人:JAY K TRAUTMAN
-
依托单位:
Automating Array Production for High-resolution Three-dimensional Proteomic Imagi
-
批准号:8394524
-
项目类别:
-
资助金额:$23.52万
-
财政年份:2012
-
负责人:JAY K TRAUTMAN
-
依托单位:
Pharmaceutical Therapy for Seasonal Affective Disorder
-
批准号:7908610
-
项目类别:
-
资助金额:$35.0万
-
财政年份:2010
-
负责人:JAY K TRAUTMAN
-
依托单位:
HIGH THROUGHPUT, LOW COST, SINGLE MOLECULE DNA SEQUENCIN
-
批准号:2680263
-
项目类别:
-
资助金额:$115.17万
-
财政年份:1998
-
负责人:JAY K TRAUTMAN
-
依托单位:
HIGH THROUGHPUT, LOW COST, SINGLE MOLECULE DNA SEQUENCIN
-
批准号:2889705
-
项目类别:
-
资助金额:$99.32万
-
财政年份:1998
-
负责人:JAY K TRAUTMAN
-
依托单位:
HIGH THROUGHPUT, LOW COST, SINGLE MOLECULE DNA SEQUENCIN
-
批准号:6181641
-
项目类别:
-
资助金额:$107.42万
-
财政年份:1998
-
负责人:JAY K TRAUTMAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: